相关实验视频

Updated: Jan 16, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

[在痴呆症诊断中的神经成像:最新]

Akihiko Shiino¹

¹Department of Neurosurgery, Shiga University of Medical Science.

No shinkei geka. Neurological surgery

|October 6, 2025

概括

用粉样蛋白和蛋白PETs进行分子成像有助于阿尔茨海默病 (AD) 的诊断. 将这些与MRI和基于voxel的形态测量相结合,有助于将AD与其他疾病区分开来,改善患者的护理.

科学领域:

神经学神经学
放射学放射学是一门学科.
分子成像学分子成像学

背景情况:

针对阿尔茨海默病 (AD) 的单克隆抗体治疗需要先进的诊断技术.
分子向成像,特别是正子发射断层扫描 (PET),对于在体内检测神经病理变化的关键,如粉样β和tau.
广泛使用的成像模式,如MRI和SPECT,对于一般门诊护理仍然很重要.

研究的目的:

根据美国放射学学院的建议,审查对阿尔茨海默病 (AD) 神经成像技术的临床实用性.
用PET成像分析体内粉样蛋白和蛋白病理的时间进展.
通过使用ADNI数据库,研究在轻度认知障碍中区分AD连续与皮下神经病性斑块 (SNAP) 的方法.

主要方法:

美国放射学学院对阿尔茨海默氏症患者神经成像指南的审查.
对粉样蛋白和蛋白PET成像数据的时间进展的分析.
利用ADNI数据库应用基于voxel的形态测量和评估轻度认知障碍患者的"皮质签名".

主要成果:

准确评估"皮质签名"对于AD诊断至关重要.
基于voxel的形态测量表明皮质缩与TAU PET病变的程度相关.
皮质和海马缩的确认为识别AD提供了诊断见解.

结论:

用粉样蛋白和蛋白PETs进行分子成像正在推进AD诊断和分期.
将PET发现与MRI和基于voxel的形态测量相结合,有助于区分AD与其他疾病,如SNAP.
这些先进的成像技术对于监测治疗方法和改善AD的临床管理至关重要.

更多相关视频

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

相关概念视频

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...